Stephen Davis

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stephen Davis

Earlier roles on record: Board Member at Heron Therapeutics, Inc. /De/ (HRTX) until February 21, 2023. Heron Therapeutics, Inc. /De/ reported in an 8-K filed February 22, 2023 that Stephen Davis resigned as director, effective February 21, 2023.

“Directors Stephen Davis and Kimberly Manhard resigned as members of the Board effective February 21, 2023.”

Heron Therapeutics, Inc. /De/ Form 8-K, filed February 22, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Stephen Davis's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Heron Therapeutics, Inc. /De/ (HRTX)
Board Member

Proxy statement

Start not stated–2023-02-21

Company network

Recorded roles and call appearances connecting this person to public companies.

Heron Therapeutics, Inc. /De/

HRTX

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: director Heron Therapeutics, Inc. /De/ (HRTX)
2023-02-21